Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) reported progress toward its climate goals in fiscal 2026, including validation of its greenhouse gas reduction targets by the Science Based Targets initiative (SBTi). The SBTi approved targets to cut absolute Scope 1 and 2 emissions 70% by fiscal 2031 from a fiscal 2025 baseline and to have 81% of suppliers by spend set science-based targets by fiscal 2030.

According to Bio-Techne, market-based Scope 1 and 2 emissions fell 49% year-over-year, the company completed its first comprehensive Scope 3 emissions inventory, and renewable sources now provide 51% of its electricity. The Minneapolis headquarters moved to 100% renewable electricity, and renewable electricity procurement began for the St. Paul GMP facility.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Fiscal 2026 highlights:

• Science Based Targets initiative validates Bio-Techne's Scope 1, 2 and 3 greenhouse gas reduction targets
• Market-based Scope 1 and 2 emissions reduced 49% year-over-year
• More than half of the company's electricity consumption now comes from renewable sources
• First comprehensive Scope 3 emissions inventory completed

MINNEAPOLIS, Sept. 1, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced significant progress toward its climate and sustainability objectives, including validation of its greenhouse gas reduction targets by the Science Based Targets initiative (SBTi) and substantial reductions in operational emissions during fiscal year 2026.

The SBTi validated Bio-Techne's targets to reduce absolute Scope 1 and 2 greenhouse gas emissions by 70% by fiscal year 2031 from a fiscal year 2025 baseline and to commit that 81% of suppliers by spend covering purchased goods and services, capital goods, upstream transportation and distribution and business travel will have science-based targets by fiscal year 2030.

Validation of the greenhouse gas reduction targets provides customers, suppliers and other stakeholders with independent confirmation that the Company's climate goals are aligned with recognized global standards and climate science.

"Our Science Based Targets validation and progress against those targets demonstrate Bio-Techne's commitment to growing responsibly," said Kim Kelderman, President and Chief Executive Officer of Bio-Techne. "As we support scientific and diagnostic innovation around the world, we are also taking meaningful steps to reduce our environmental impact and strengthen sustainability across our operations and value chain."

Bio-Techne also expanded its use of renewable electricity during the year. The company transitioned its Minneapolis headquarters to 100% renewable electricity and began procuring renewable electricity for its St. Paul GMP facility. As a result, renewable sources now account for 51% of Bio-Techne's total electricity consumption.

ABOUT BIO-TECHNE

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company headquartered in Minnesota, celebrating 50 years of empowering scientific and diagnostic communities to reach better answers. The company provides high-quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer-focused brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical decision-making. Bio-Techne operates in 34 locations worldwide and employs more than 3,000 people. In fiscal year 2026, the company generated over $1.2 billion in net sales. Its more than 500,000 products are used globally by academic researchers, biopharmaceutical and biotechnology companies, and clinical diagnostic laboratories.

CONTACT:

Corporate Communications
media.relations@bio-techne.com

David Clair, Vice President
Investor Relations
IR@bio-techne.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-achieves-science-based-targets-validation-and-reports-significant-progress-toward-climate-goals-302865718.html

SOURCE Bio-Techne Corporation

FAQ

What climate milestones did Bio-Techne (NASDAQ: TECH) report for fiscal 2026?

Bio-Techne reported SBTi validation of its greenhouse gas targets, a 49% year-over-year reduction in market-based Scope 1 and 2 emissions, completion of its first comprehensive Scope 3 inventory, and renewable sources reaching 51% of electricity use, according to Bio-Techne’s fiscal 2026 climate progress disclosure.

What Science Based Targets did Bio-Techne (TECH) have validated in September 2026?

The Science Based Targets initiative validated Bio-Techne’s targets to reduce absolute Scope 1 and 2 emissions 70% by fiscal 2031 from a 2025 baseline and to ensure 81% of suppliers by spend have science-based targets by fiscal 2030, according to Bio-Techne.

How much did Bio-Techne reduce its Scope 1 and 2 emissions in fiscal 2026?

Bio-Techne reduced its market-based Scope 1 and 2 greenhouse gas emissions by 49% year-over-year in fiscal 2026. According to Bio-Techne, this reduction supports progress toward its validated 2031 emissions target and reflects operational and energy sourcing changes across key facilities.

What share of Bio-Techne’s electricity came from renewable sources in fiscal 2026?

Renewable sources provided 51% of Bio-Techne’s total electricity consumption in fiscal 2026. According to Bio-Techne, its Minneapolis headquarters transitioned to 100% renewable electricity and the company began procuring renewable electricity for its St. Paul GMP facility during the year.

What is included in Bio-Techne’s Scope 3 emissions goals validated by SBTi?

Bio-Techne’s Scope 3-related goal is that 81% of suppliers by spend will have science-based targets by fiscal 2030. According to Bio-Techne, this covers purchased goods and services, capital goods, upstream transportation and distribution, and business travel across its value chain.

Did Bio-Techne complete a Scope 3 greenhouse gas emissions inventory in 2026?

Yes, Bio-Techne completed its first comprehensive Scope 3 greenhouse gas emissions inventory in fiscal 2026. According to Bio-Techne, this inventory supports its validated Science Based Targets and provides a foundation for managing emissions across its broader supply chain and value chain.